Swedbank
BMY icon

Swedbank’s Bristol-Myers Squibb BMY Stock Holding History

Swedbank’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$154M Sell
2,472,114
-571,091
-19% -$36.1M 0.13% 125
2026
Q2 		$175M Buy
3,043,205
+81,526
+3% +$4.68M 0.15% 114
2026
Q1 		$180M Sell
2,961,679
-17,734
-0.6% -$1.03M 0.19% 100
2025
Q4 		$161M Buy
2,979,413
+5,572
+0.2% +$268K 0.16% 111
2025
Q3 		$134M Buy
2,973,841
+15,611
+0.5% +$729K 0.14% 128
2025
Q2 		$137M Sell
2,958,230
-121,961
-4% -$5.99M 0.15% 115
2025
Q1 		$188M Sell
3,080,191
-105,483
-3% -$6.15M 0.25% 87
2024
Q4 		$180M Buy
3,185,674
+46,122
+1% +$2.58M 0.22% 94
2024
Q3 		$162M Buy
3,139,552
+28,427
+0.9% +$1.33M 0.21% 97
2024
Q2 		$129M Buy
3,111,125
+193,486
+7% +$8.66M 0.17% 104
2024
Q1 		$158M Buy
2,917,639
+803,722
+38% +$40.9M 0.22% 92
2023
Q4 		$108M Buy
2,113,917
+3,059
+0.1% +$161K 0.17% 104
2023
Q3 		$123M Buy
2,110,858
+2,866
+0.1% +$176K 0.21% 92
2023
Q2 		$135M Sell
2,107,992
-11,049
-0.5% -$741K 0.23% 88
2023
Q1 		$147M Buy
2,119,041
+63,860
+3% +$4.5M 0.29% 72
2022
Q4 		$148M Buy
2,055,181
+83,399
+4% +$6.29M 0.33% 68
2022
Q3 		$140M Sell
1,971,782
-3,304
-0.2% -$240K 0.33% 64
2022
Q2 		$152M Sell
1,975,086
-71,639
-4% -$5.46M 0.34% 61
2022
Q1 		$149M Buy
2,046,725
+20,523
+1% +$1.38M 0.28% 80
2021
Q4 		$127M Buy
2,026,202
+27,390
+1% +$1.61M 0.21% 103
2021
Q3 		$118M Buy
1,998,812
+50,696
+3% +$3.34M 0.22% 99
2021
Q2 		$130M Buy
1,948,116
+109,400
+6% +$7.13M 0.24% 87
2021
Q1 		$116M Buy
1,838,716
+46,514
+3% +$2.89M 0.24% 99
2020
Q4 		$111M Buy
1,792,202
+28,186
+2% +$1.73M 0.33% 92
2020
Q3 		$106M Buy
1,764,016
+2,245
+0.1% +$135K 0.37% 80
2020
Q2 		$104M Buy
1,761,771
+15,351
+0.9% +$918K 0.38% 82
2020
Q1 		$97.3M Sell
1,746,420
-82,215
-4% -$5.03M 0.48% 70
2019
Q4 		$117M Buy
+1,828,635
New +$105M 0.47% 78

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Swedbank's BMY Position: Q3 2026 in Review

Swedbank reduced its Bristol-Myers Squibb (BMY) stake by 19% in Q3 2026, selling an estimated $36.1M and leaving 2,472,114 shares worth $154M. The position accounts for 0.13% of the portfolio, ranked #125.

Swedbank first reported a position in BMY in Q4 2019 and has held it in 28 quarters since. The position peaked at $188M in Q1 2025. 1,035 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Swedbank held 2,472,114 shares of Bristol-Myers Squibb worth $154M as of Q3 2026.
  • Swedbank sold 571,091 Bristol-Myers Squibb shares in Q3 2026, an estimated $36.1M.
  • Bristol-Myers Squibb made up 0.13% of Swedbank's portfolio in Q3 2026, its #125 holding.
  • Swedbank first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 28 quarters since.
  • Swedbank's Bristol-Myers Squibb position peaked at $188M in Q1 2025.
  • 1,035 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.